Omeros (OMER)
(Delayed Data from NSDQ)
$3.92 USD
-0.11 (-2.73%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.93 +0.01 (0.26%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OMER 3.92 -0.11(-2.73%)
Will OMER be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for OMER based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OMER
Brian's Big Idea on Biotech
Take the Zacks Approach to Beat the Market: Shopify, Oracle, Uber in Focus
OMER: What are Zacks experts saying now?
Zacks Private Portfolio Services
Avis Budget Group and Vulcan Materials have been highlighted as Zacks Bull and Bear of the Day
3 Medical Stocks Creating Wealth Despite Macro Challenges
Wall Street Analysts See a 126% Upside in Omeros (OMER): Can the Stock Really Move This High?
Other News for OMER
Omeros Corporation (OMER) Q2 2024 Earnings Call Transcript
Needham Sticks to Its Hold Rating for Omeros (OMER)
Omeros Corp (OMER) Q2 2024 Earnings Call Transcript Highlights: Financial Cushion and Clinical ...
Omeros: Q2 Earnings Snapshot
Omeros Corporation Reports Second Quarter 2024 Financial Results